Pain is challenging, but it doesn't have to define your life. Episode 2 of Get Tough on Multiple Sclerosis offers practical ...

Three medications have spasticity reduction as their primary ... A progressive disease such as multiple sclerosis might be better managed using an intervention that can escalate as the disease ...

A controversial bill that would outlaw all THC products in Texas has passed the Senate and is now in the hands of the House, ...

GW specialises in drugs developed from cannabis plants, and already has Sativex (nabiximols) approved in markets including the UK for multiple sclerosis spasticity. However Sativex failed in a ...

It is common for individuals to suffer from headaches from time to time, but when they are frequent, almost like a daily ...

Quantum is partnering with Massachusetts General Hospital on a clinical study to test a PET tracer for monitoring response to ...

Previous research has shown that vitamin D deficiency can increase the risk of multiple sclerosis (MS) — and a new study suggests that supplementing it in high doses could help reduce symptoms.

Background OnabotulinumtoxinA has demonstrated significant benefit in adult focal spasticity. This study reviews the injection patterns (i.e., muscle distribution, dosing) of onabotulinumtoxinA ...

Thousands more patients with multiple sclerosis in England will soon be able to access Merck KGaA's take-at-home tablet Mavenclad, reducing their need for clinic visits. New guidance (PDF ...

Czech doctors have been authorized to prescribe medicinal cannabis to patients suffering from intractable chronic pain.

Quadriparesis is when there is muscle weakness in both arms and both legs. It is different than quadriplegia, which causes paralysis (complete loss of movement) in each of the body’s limbs. The ...